| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/08/2011 | USRE42129 DNA based tests for the presence of the obesity associated virus adenovirus type 36; for reducing levels of triglycerides and cholesterol in humans |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884192 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884191 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884184 comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region; suppressing an antigen-specific immune response to a target antigen; Autoimmune disease |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884129 plant extracts comprising dehyrodiconiferyl alcohol, used for inhibiting adipocyte differentiation, inhibiting triglyceride synthesis, activating peroxisome proliferator-activated receptors(PPAR-alpha) and reducing body weight; anticholesterol agents |
| 02/08/2011 | US7884083 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 02/08/2011 | US7883889 Using 5-aza-cytidine or 5-aza-2'-deoxycytidine to hypomethylate cells expressing tumor associated antigens; immunotherapy; genetic vaccines and the diagnosis, prevention and treatment of cancer |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
| 02/08/2011 | US7883876 Neisseria meningitidis serogroup A capsular polysaccharide acetyltransferase, methods and compositions |
| 02/08/2011 | US7883857 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 02/08/2011 | US7883845 using Human immunodeficiency virus-1 group O/M envelope polypeptide fusion as evaluative tool in diagnosing viral infection |
| 02/08/2011 | US7883843 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 02/08/2011 | US7883712 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti |
| 02/08/2011 | US7883711 Use of polypeptides having antimicrobial activity |
| 02/08/2011 | US7883710 Peptide vaccines against Group A streptococci |
| 02/08/2011 | US7883709 Stabilised compositions |
| 02/08/2011 | US7883707 Induction of antigen specific immunnologic tolerance |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | US7883705 used as a hypophosphatemia treatment having a more sustained raising action for serum phosphate concentration and serum 1,25D concentration with a single dose; with few side effects; osteoporosis, rickets, hypocalcaemia, calcification, osteosclerosis, Paget's disease, parathyroidism and pruritis |
| 02/08/2011 | US7883704 Methods for inhibiting the activity of the P40 subunit of human IL-12 |
| 02/08/2011 | US7883703 Methods of modulating immunity |
| 02/08/2011 | US7883702 Use of anti-mortalin 2 antibody and functional nucleic acid for cancer therapies |
| 02/08/2011 | US7883701 Administering to animal an agent that can reduce the formation of the signal transduction complex of endotoxin, toll-like receptor 4 (TLR4) and CD14 on the cellular surface of a cell in the gastrointestinal tract of the animal |
| 02/08/2011 | US7883700 Anti-human IL-21 monoclonal antibodies |
| 02/08/2011 | US7883697 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 02/08/2011 | CA2641585C Capsular polysaccharide solubilisation and combination vaccines |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2403292C Microbial delivery system |
| 02/08/2011 | CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 02/08/2011 | CA2350207C T cells specific for target antigens and methods and vaccines based thereon |
| 02/08/2011 | CA2341574C Phosphohalohydrins, method for making same and uses |
| 02/08/2011 | CA2328321C Combination vaccine for enhancing immunity against brucellosis |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
| 02/08/2011 | CA2284586C Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/03/2011 | WO2011014872A2 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 02/03/2011 | WO2011014871A1 Programming of cells for tolerogenic therapies |
| 02/03/2011 | WO2011014863A2 Prophylaxis against cancer metastasis |
| 02/03/2011 | WO2011014797A1 Antibacterial compositions for drug administration |
| 02/03/2011 | WO2011014750A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | WO2011014726A1 Mtor inhibitor and angiogenesis inhibitor combination therapy |
| 02/03/2011 | WO2011014679A1 Method and kit for treating nicotine addiction |
| 02/03/2011 | WO2011014659A2 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | WO2011014504A1 Recombinant influenza virus vectors and uses thereof |
| 02/03/2011 | WO2011014469A1 High affinity human antibodies to human angiopoietin-2 |
| 02/03/2011 | WO2011014457A1 Combination treatments |
| 02/03/2011 | WO2011014438A1 Fully human antibodies to btla |
| 02/03/2011 | WO2011014416A2 High yield yellow fever virus strain with increased propagation in cells |
| 02/03/2011 | WO2011013786A1 Cancer metastasis inhibitor |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011013302A1 Agent for treatment or prevention of hepatitis |
| 02/03/2011 | WO2011013034A1 Antigenic tau peptides and uses thereof |
| 02/03/2011 | WO2011012999A1 Reverse genetics systems |
| 02/03/2011 | WO2011012662A1 Mycobacterium mutants for vaccines with improved protective efficacy |
| 02/03/2011 | WO2011011971A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 02/03/2011 | WO2011011879A1 H. pylori lipopolysaccharide outer core epitope |
| 02/03/2011 | WO2011011873A1 Sticky soft gel for treating poultry |
| 02/03/2011 | WO2010144611A3 Antivirals that target transporters, carriers, and ion channels |
| 02/03/2011 | WO2010134094A9 Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva) |
| 02/03/2011 | WO2010129457A9 Vaccines against tularemia |
| 02/03/2011 | WO2010124276A3 Anti-tgf-beta induction of bone cell function and bone growth |
| 02/03/2011 | WO2010115868A3 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation |
| 02/03/2011 | WO2010106187A3 Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders |
| 02/03/2011 | WO2010059969A8 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer |
| 02/03/2011 | WO2010018003A3 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 02/03/2011 | WO2009132050A9 Auris formulations for treating otic diseases and conditions |
| 02/03/2011 | WO2008052173A8 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 02/03/2011 | WO2007035872A3 Tdf-related compounds and analogs thereof |
| 02/03/2011 | US20110030108 Mammalian-type glycosylation in plants |
| 02/03/2011 | US20110030077 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTalpha-OSTbeta) ACTIVITY AND TREATING ASSOCIATED CONDITIONS |
| 02/03/2011 | US20110030074 Compositions and methods for cancer gene discovery |
| 02/03/2011 | US20110030073 Therapeutic targets and medicaments involving p230/golgin-245 |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027349 Polypeptide vaccine and vaccination strategy against mycobacterium |
| 02/03/2011 | US20110027323 Adjuvants and methods of use |
| 02/03/2011 | US20110027322 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy |
| 02/03/2011 | US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides |
| 02/03/2011 | US20110027319 Methods of eliciting or boosting a cellular immune response |
| 02/03/2011 | US20110027318 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
| 02/03/2011 | US20110027317 Production of poliovirus at high titers for vaccine production |
| 02/03/2011 | US20110027316 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| 02/03/2011 | US20110027315 Protein cages and their uses |
| 02/03/2011 | US20110027314 Influenza Vaccines Containing Hemagglutinin and Matrix Proteins |
| 02/03/2011 | US20110027313 Viral recombineering and uses thereof |
| 02/03/2011 | US20110027312 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| 02/03/2011 | US20110027311 Combination of protein vaccine and mesenchymal stem cells for treating cancer |
| 02/03/2011 | US20110027310 Compositions and Methods for Cancer Treatment |
| 02/03/2011 | US20110027309 Compositions and methods of enhancing immune responses |
| 02/03/2011 | US20110027308 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 02/03/2011 | US20110027307 Anti-sepsis conjugate vaccine |
| 02/03/2011 | US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods |
| 02/03/2011 | US20110027304 Yersinia pestis antigens, vaccine compositions and related methods |